Table 2 Comparison of patient characteristics between the study groups.
Characteristics | Low | High | p-value |
---|---|---|---|
(N = 72) | (N = 67) | ||
Sex (male vs. female) | 37 vs. 45 | 29 vs. 40 | 0.74 |
Age (years) | 72.5 (46–87) | 70 (34–89) | 0.14 |
Body mass index | 21.1 ± 0.4 | 23.5 ± 0.4 | < 0.001 |
ASA classification, n (%) | |||
1 or 2 | 68 (94.4) | 62 (92.5) | 0.74 |
3 | 4 (5.6) | 5 (7.5) | |
Diabetes mellitus, n (%) | 30 (41.7) | 25 (37.3) | 0.61 |
Neoadjuvant chemotherapy (%) | 7 (9.7) | 5 (7.5) | 0.77 |
Preoperative albumin (g/L) | 3.5 ± 0.1 | 4.2 ± 0.1 | < 0.001 |
DP or PD | 21/51 | 35/32 | 0.04 |
Operation time (min) | 529.6 ± 20.2 | 483.9 ± 17.9 | 0.11 |
Estimated blood loss (mL) | 889.4 ± 95.1 | 950.9 ± 89.6 | 0.65 |
POCs (CD grade over IIIa, %) | 26 (36.1) | 7 (10.4) | 0.001 |
Stage I, II/III, IV | 64/8 | 61/6 | 0.78 |
Postoperative hospital stays (days) | 34.9 ± 2.9 | 29.6 ± 1.8 | 0.11 |
AC Induction (%) | 56 (77.8) | 54 (80.6) | 0.68 |
AC Completion (%) | 29 (51.8) | 34 (63.0) | 0.23 |
Time to AC after surgery (days) | 54.5 ± 5.7 | 42.5 ± 3.3 | 0.07 |